Glucagon-like peptide-1 receptor agonists (GLP-1s) mimic a natural hormone, primarily used for type 2 diabetes by regulating blood sugar and appetite and are increasingly used for weight loss by slowing gastric emptying and increasing fullness (Catanese, 2024)
GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion
But for people with lupus, the big question is whether these medications are safe and whether they might offer additional benefits or risks
What does carry over is anything structural you built during the cycle: muscle, training capacity, insulin sensitivity gains that follow from lower fat mass, and eating patterns you can maintain
Los investigadores exploran sistemas de administracin avanzados